Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regulus Therapeutics Inc (NASDAQ:RGLS)

2.50
Delayed Data
As of 2:07pm ET
 -0.10 / -3.85%
Today’s Change
2.13
Today|||52-Week Range
10.18
-71.33%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close2.60
Today’s open2.60
Day’s range2.35 - 2.70
Volume478,402
Average volume (3 months)410,812
Market cap$137.6M
Dividend yield--
Data as of 2:07pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+16.28%
Earnings growth (this year)-40.12%
Earnings growth (next 5 years)--
Revenue growth (last year)+170.69%
P/E ratioNM
Price/Sales21.60
Price/Book1.10

Competitors

 Today’s
change
Today’s
% change
AKAOAchaogen Inc+0.32+6.36%
ATHXAthersys Inc+0.03+1.87%
XENEXenon Pharmaceutical...+0.20+2.56%
CTICCTi Biopharma Corp-0.00-0.06%
Data as of 2:19pm ET, 12/09/2016

Financials

Next reporting dateFebruary 22, 2017
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$20.8M
Annual profit (last year)-$55.7M
Net profit margin-268.55%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
COO, Principal Financial &
Accounting Officer
Joseph P. Hagan
Corporate headquarters
San Diego, California

Forecasts


Search for Jobs